Embryo transfer at the blastocyst stage improves pregnancy and live-birth rates in egg donation treatments

Embryo transfer at the blastocyst stage improves pregnancy and live-birth rates in egg donation treatments

Embryo transfer at the blastocyst stage improves pregnancy and live-birth rates in egg donation treatments

The study, led by the biologist Dr Elisabet Clua, head of the Oocyte and Embryo Donation Programme at Dexeus Mujer, was carried out at this centre between April 2017 and August 2018. The sample of women under study were recipients of donated oocytes, aged between 18 and 50 years, in their first or second synchronous cycle (excluding PGT-A cycles, patients with recurrent implantation failure, as well as patients with partners presenting with a severe male factor).

The main variable was the cumulative live-birth rate within 12 months after the first embryo transfer (i.e., considering the transfer of fresh and cryopreserved embryos). In addition, the period of time between the first embryo transfer and the first child being born, as well as the cost per child born, were also considered. A total of 134 recipients were randomly included in either the day-3 transfer group (D3, n=69) or in the day-5 transfer group (D5, n=65).

According to the results, in the blastocyst transfer group, there was a 15.9% relative increase in the cumulative live-birth rate. The time to birth was significantly shorter compared to the D3 group. To reach a 50% cumulative live-birth rate, the D3 group needed 6 months more than the D5 group (15.3 vs. 8.9 months, respectively). Moreover, the average cost in the D3 strategy was 24% higher than in the D5 strategy (14,817.1 euros vs. 10,959.2 euros) and the clinical pregnancy rate was approximately 25% lower in the D3 group.

According to the authors, the study demonstrates that blastocyst-stage embryo transfer in recipients of donated oocytes is the preferred option, as it leads to a higher live-birth rate, shorter time to birth and lower costs to achieve a pregnancy, compared to the transfer of early-stage embryos.

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.

¿Cómo podemos ayudarte?

Te informamos que los datos de carácter personal que proporciones rellenando el presente formulario serán tratados por Fundación Dexeus Mujer como responsable de esta web. La finalidad de la recogida y tratamiento de estos datos es contactar contigo en referencia a tu solicitud y en caso de que expresamente nos autorices enviarte información sobre actividades, promociones y/o servicios y nuestro boletín informativo periódico. La legitimación se realiza a través del consentimiento del interesado. Podrás ejercer tus derechos de acceso, rectificación, limitación y suprimir los datos ante el delegado de protección de datos en dpd@dexeus.com así como el derecho a presentar una reclamación ante una autoridad de control. Puedes consultar la información adicional y detallada sobre Protección de Datos en nuestra política de privacidad.